Ultragenyx Pharmaceutical | RARE - Operating Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical reported $-154105000 in Operating Profit for its fiscal quarter ending in March of 2023.


Operating Profit Change
Acadia Pharmaceuticals ACAD:US USD -53584000 7.52M
Agios Pharmaceuticals AGIO:US USD -90613000 119.29M
Alnylam Pharmaceuticals ALNY:US USD -149807000 38.81M
BioCryst Pharmaceuticals BCRX:US USD -28415000 17.9M
BioMarin Pharmaceutical BMRN:US USD 59.35M 83.85M
Bluebird Bio BLUE:US USD 8.44M 17M
Esperion Therapeutics ESPR:US USD -48605000 6.09M
Immunic Inc. VTL:US USD -27251000 30.08M
Insmed INSM:US USD -148158000 3.32M
Ionis Pharmaceuticals IONS:US USD -114148000 93.87M
Karyopharm Therapeutics KPTI:US USD -30899000 2.97M
Kyowa Hakko Kirin 4151:JP JPY 14.62B 6.1B
MacroGenics MGNX:US USD -38426000 50.41M
Mirati Therapeutics MRTX:US USD -193823000 17.9M
Moderna Inc MRNA:US USD -366000000 1.95B
Neurocrine Biosciences NBIX:US USD -114200000 217.6M
PTC Therapeutics PTCT:US USD -117615000 82.73M
Puma Biotechnology PBYI:US USD 4.36M 6.71M
Regeneron Pharmaceuticals REGN:US USD 946.7M 200.1M
Sarepta Therapeutics SRPT:US USD -525417000 416.01M
Ultragenyx Pharmaceutical RARE:US USD -154105000 8.48M
Vertex Pharmaceuticals VRTX:US USD 779M 254.5M
Xoma XOMA:US USD -10170000 3.96M